Financials

Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
1797
MBX
MBX Biosciences, Inc. - Common Stock
56.59 USD-5.75%-9.22%+43.81%+304.21%2.69 B USD
1930
PVLA
Palvella Therapeutics, Inc. - Common Stock
149.68 USD+2.50%+5.18%+27.93%+102.68%2.15 B USD
2056
GENB
Generate Biomedicines, Inc. - Common Stock
14.21 USD-0.49%-9.66%+5.57%-5.27%1.82 B USD
2131
MAZE
Maze Therapeutics, Inc. - Common Stock
29.88 USD+2.40%-9.01%+23.68%-33.64%1.65 B USD